Allovir

Developer of T-cell therapies to treat infectious diseases

placeHouston, Texas, United States calendar_todayFounded 2013 groups97 employees language allovir.com

Registered entities

Investor mix

12 investors on record; lead investors include Fidelity Investments.

Investor typeCountShare
Venture capital325%
Private equity18%
Bank & private debt18%
Other / undisclosed758%
Coming soon